UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension

Clinical gastroenterology and hepatology, 2023-07, Vol.21 (7), p.1854-1863.e10

2023

Volltextzugriff (PDF)

Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis

Liver international, 2023-10, Vol.43 (10), p.2220-2231

2023

Volltextzugriff (PDF)

Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update

Cells (Basel, Switzerland), 2022-11, Vol.11 (22), p.3531

2022

Volltextzugriff (PDF)

Non-invasive tests-based risk stratification: Baveno VII and beyond

Clinical and Molecular Hepatology, 2023, 29(1), , pp.105-109

2023

Volltextzugriff (PDF)

Endoscopic band ligation is safe despite low platelet count and high INR

Hepatology international, 2023-10, Vol.17 (5), p.1205-1214

2023

Volltextzugriff (PDF)

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder

European radiology, 2023-02, Vol.33 (2), p.1422-1432

2023

Volltextzugriff (PDF)

The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Scientific reports, 2023-01, Vol.13 (1), p.953-953, Article 953

2023

Volltextzugriff (PDF)

Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study

Scientific reports, 2024-07, Vol.14 (1), p.17558-11, Article 17558

2024

Volltextzugriff (PDF)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event

JHEP reports, 2022-08, Vol.4 (8), p.100513, Article 100513

2022

Volltextzugriff (PDF)

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach

Clinics in liver disease, 2021-05, Vol.25 (2), p.311-326

2021

Volltextzugriff (PDF)

Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis

JHEP reports, 2023-05, Vol.5 (5), p.100712-100712, Article 100712

2023

Volltextzugriff (PDF)

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

JHEP reports, 2023-04, Vol.5 (4), p.100682-100682, Article 100682

2023

Volltextzugriff (PDF)

COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality

Hepatology communications, 2021-10, Vol.5 (10), p.1660-1675

2021

Volltextzugriff (PDF)

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

JHEP reports, 2023-08, Vol.5 (8), p.100751-100751, Article 100751

2023

Volltextzugriff (PDF)

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD

JHEP reports, 2024-01, Vol.6 (1), p.100934-100934, Article 100934

2024

Volltextzugriff (PDF)

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis

JHEP reports, 2023-08, Vol.5 (8), p.100789-100789, Article 100789

2023

Volltextzugriff (PDF)

Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality

JHEP reports, 2024-01, Vol.6 (1), p.100954-100954, Article 100954

2024

Volltextzugriff (PDF)

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19

Journal of personalized medicine, 2021-12, Vol.11 (12), p.1264

2021

Volltextzugriff (PDF)

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression

Journal of personalized medicine, 2022-02, Vol.12 (2), p.239

2022

Volltextzugriff (PDF)

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease

JHEP reports, 2022-11, Vol.4 (11), p.100562-100562, Article 100562

2022

Volltextzugriff (PDF)

Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis

Hepatology communications, 2022-09, Vol.6 (9), p.2569-2580

2022

Volltextzugriff (PDF)

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers

Clinics in liver disease, 2021-05, Vol.25 (2), p.311-326

2021

Volltextzugriff (PDF)

Reply to: “3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta”

Journal of hepatology, 2023-07, Vol.79 (1), p.e49-e50

2023

Volltextzugriff (PDF)

Immunotherapy for hepatocellular carcinoma in a patient with hepatitis B virus and hepatitis delta virus coinfection

Journal of hepatology, 2022-07, Vol.77 (1), p.256-257

2022

Volltextzugriff (PDF)

Letter: chronic HDV infection—is ignorance bliss? Authors' reply

Alimentary pharmacology & therapeutics, 2023-02, Vol.57 (3), p.359-360

2023

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(152)
Buchkapitel
(1)

Sprache

Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension

Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis

Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update

Non-invasive tests-based risk stratification: Baveno VII and beyond

Endoscopic band ligation is safe despite low platelet count and high INR

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder

The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach

Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis

Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease

Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers

Reply to: “3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta”

Immunotherapy for hepatocellular carcinoma in a patient with hepatitis B virus and hepatitis delta virus coinfection

Letter: chronic HDV infection—is ignorance bliss? Authors' reply

Aktive Filter

Suchergebnisse filtern